The initial public offer (IPO) of Eris Lifesciences Ltd opened for subscription on Friday, with a price band of Rs600-603 apiece. The Ahmedabad-based company is planning to raise Rs1,741.1 crore through the issue which closes on 20 June. The IPO is an offer for sale and will not raise any primary capital.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
